Details of Disease

General Information of Disease (ID: DISMR2WD)

Disease Name	Condyloma
Synonyms	benign eccrine tumour of the skin; benign eccrine neoplasm; benign eccrine skin tumour; benign eccrine tumor of the skin; benign eccrine tumor; benign eccrine tumor of skin; eccrine sweat gland neoplasm, benign; benign eccrine skin tumor; benign eccrine skin neoplasm; benign eccrine neoplasm of the skin; benign skin tumor with eccrine differentiation; benign eccrine tumour of skin; benign eccrine tumour; benign eccrine sweat gland neoplasm; benign eccrine neoplasm of skin; benign skin tumour with eccrine differentiation
Disease Class	1A61-1A6Z: Syphilis
Definition	A non-metastasizing eccrine appendage sweat gland neoplasm. Representative examples include hidrocystoma, syringoma, and syringofibroadenoma.
Disease Hierarchy	DIS42J3U: Eccrine sweat gland neoplasm DISRJ557: Benign neoplasm of sweat gland DISMR2WD: Condyloma
ICD Code	ICD-11 ICD-11: 1A95
Disease Identifiers	MONDO ID MONDO_0024247 UMLS CUI C1332493 MedGen ID 231934 SNOMED CT ID 19672005

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Imiquimod	DM1TMA3	Approved	Small molecular drug	[1]
Podofilox	DMT2EJP	Approved	Small molecular drug	[2]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
AP-611074	DMVMXYK	Phase 1/2	NA	[3]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Hsp 6/11	DMNV1KR	Investigative	NA	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Imiquimod FDA Label
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	ClinicalTrials.gov (NCT01532102) Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts. U.S. National Institutes of Health.
4	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.